Keybank National Association OH Purchases 229 Shares of Agilent Technologies Inc (NYSE:A)

Keybank National Association OH grew its position in Agilent Technologies Inc (NYSE:A) by 0.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 59,694 shares of the medical research company’s stock after purchasing an additional 229 shares during the quarter. Keybank National Association OH’s holdings in Agilent Technologies were worth $4,574,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of A. Flagship Harbor Advisors LLC boosted its stake in shares of Agilent Technologies by 139.0% in the 2nd quarter. Flagship Harbor Advisors LLC now owns 349 shares of the medical research company’s stock valued at $26,000 after purchasing an additional 203 shares during the last quarter. Capital Investment Advisory Services LLC bought a new position in Agilent Technologies during the second quarter worth $26,000. Liberty Wealth Management LLC bought a new position in Agilent Technologies during the second quarter worth $29,000. WealthStone Inc. bought a new position in Agilent Technologies during the second quarter worth $31,000. Finally, Coastal Capital Group Inc. bought a new position in Agilent Technologies during the second quarter worth $32,000.

NYSE A traded up $0.73 during trading hours on Friday, reaching $76.64. 1,157,853 shares of the company were exchanged, compared to its average volume of 2,235,919. Agilent Technologies Inc has a 1 year low of $62.00 and a 1 year high of $82.27. The business’s 50 day simple moving average is $75.70 and its 200-day simple moving average is $72.83. The company has a quick ratio of 1.72, a current ratio of 2.13 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $23.38 billion, a P/E ratio of 27.47, a P/E/G ratio of 1.88 and a beta of 1.42.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 14th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.72 by $0.04. Agilent Technologies had a net margin of 21.06% and a return on equity of 20.00%. The business had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.24 billion. During the same quarter last year, the company posted $0.67 earnings per share. The firm’s quarterly revenue was up 5.6% compared to the same quarter last year. As a group, sell-side analysts anticipate that Agilent Technologies Inc will post 3.08 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were paid a $0.164 dividend. The ex-dividend date of this dividend was Monday, September 30th. This represents a $0.66 annualized dividend and a dividend yield of 0.86%. Agilent Technologies’s payout ratio is 23.66%.

In other news, CEO Michael R. Mcmullen sold 24,635 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $77.50, for a total value of $1,909,212.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Heidi Fields sold 4,000 shares of the firm’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $78.56, for a total transaction of $314,240.00. Following the completion of the transaction, the director now owns 53,287 shares of the company’s stock, valued at $4,186,226.72. The disclosure for this sale can be found here. Insiders sold 32,635 shares of company stock valued at $2,507,293 in the last quarter.

Several brokerages recently issued reports on A. Piper Jaffray Companies increased their target price on shares of Agilent Technologies from $83.00 to $86.00 and gave the stock an “overweight” rating in a research note on Thursday, August 15th. Bank of America lowered shares of Agilent Technologies from a “buy” rating to a “neutral” rating and set a $76.00 price objective on the stock. in a research note on Tuesday, July 16th. Needham & Company LLC raised their price objective on shares of Agilent Technologies to $92.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Robert W. Baird reaffirmed an “outperform” rating and issued a $82.00 price objective (up from $79.00) on shares of Agilent Technologies in a research note on Thursday, August 15th. Finally, Zacks Investment Research lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating and set a $75.00 price objective on the stock. in a research note on Monday, August 19th. Seven analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $84.00.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Featured Article: Risk Tolerance and Your Investment Decisions

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.